#hemophiab
Live, measured metrics for the hashtag #hemophiab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #hemophiab
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · fosstodon.org (Mastodon public tags API) · fetched 2026-08-03 03:04 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · fosstodon.org (Mastodon public search API) · fetched 2026-08-03 03:04 UTCNo related tags with measured usage found for #hemophiab.
Live pulse
measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-08-03 03:04 UTCEverything below is measured over the latest 2 public posts (spanning ~1868 hours).
Posting hours (UTC)
Languages: English (2)
Avg boosts / post: 0
Top of the latest posts
Concizumab (Alhemo) for Hemophilia A or B with Inhibitors Concizumab (commercial name, Alhemo), a monoclonal antibody was approved bythe FDA on 20 December 2024 for prevention of bleeding episodes in........... #Alhemo #Concizumab #FDA #Hem
Hympavzi (marstacimab): New Treatment for Hemophilia On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval........... #bleedingdisorder #HemophiaB
#hemophiab across platforms
every network with a public tag surfaceFollow #hemophiab straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/hemophiab